InsidersTradesSigma
Track the 兰卫医学 share price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 兰卫医学 has logged 3 insider filings. Market capitalisation: €3.4bn. The latest transaction was filed on 26 March 2024 (Sale). Among the most active insiders: 孙林洁. The full history is accessible without an account.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,622 of 29,063 companies
35.1
score / 100
Value35
Quality35
FCF yld6.1%
Earn yld-0.9%
EV/EBITDA37.5x
ROE1.8%
Gross mgn24%
Net mgn-2.1%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 March 2024
Acerca de 兰卫医学
兰卫医学 es una empresa centrada en el sector sanitario y farmacéutico, que ofrece soluciones innovadoras para el diagnóstico y el tratamiento. Cotiza en el mercado XSHE.